Published in J Biol Chem on February 25, 1985
The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA. Proc Natl Acad Sci U S A (1985) 1.51
Inhibition of tyrosine sulfation in the trans-Golgi retards the transport of a constitutively secreted protein to the cell surface. J Cell Biol (1988) 0.90
Increased sensitivity of Apolipoprotein E knockout mice to swainsonine dependent immunomodulation. Immunobiology (2014) 0.77
Fibronectins--adhesive glycoproteins of cell surface and blood. Nature (1978) 8.23
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol (1994) 5.76
Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med (1992) 4.39
Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev (1993) 3.96
Levels of translatable mRNAs for cell surface protein, collagen precursors, and two membrane proteins are altered in Rous sarcoma virus-transformed chick embryo fibroblasts. Proc Natl Acad Sci U S A (1977) 3.80
Role of carbohydrates in protein secretion and turnover: effects of tunicamycin on the major cell surface glycoprotein of chick embryo fibroblasts. Cell (1978) 3.12
Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med (1994) 3.09
A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science (1986) 2.91
Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J Cell Biol (1986) 2.63
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun (1993) 2.56
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res (1999) 2.55
Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med (1994) 2.54
Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J Biol Chem (1987) 2.52
Mechanism of the decrease in the major cell surface protein of chick embryo fibroblasts after transformation. Cell (1977) 2.42
Cyclic vomiting syndrome in adults. Neurogastroenterol Motil (2008) 2.40
Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res (1996) 2.36
Carbohydrate moieties of glycoproteins. A re-evaluation of their function. Biochim Biophys Acta (1982) 2.27
Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res (1995) 2.24
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
Direct detection of antigens in sodium dodecyl sulfate-polyacrylamide gels. Anal Biochem (1977) 1.98
Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther (2002) 1.97
Evidence for role of glycoprotein carbohydrates in membrane transport: specific inhibition by tunicamycin. Proc Natl Acad Sci U S A (1979) 1.94
"Environmental justice": the central role of research in establishing a credible scientific foundation for informed decision making. Toxicol Ind Health (1994) 1.85
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med (1995) 1.78
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest (1996) 1.76
Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res (1995) 1.75
Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev (1995) 1.75
Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites. J Cell Biol (1984) 1.71
False increase of cardiac troponin I with heterophilic antibodies. Clin Chem (1998) 1.63
Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly. J Cell Biol (1991) 1.59
Heterogeneity of membrane vesicles from Escherichia coli and their subfractionation with antibody to ATPase. Proc Natl Acad Sci U S A (1974) 1.54
Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci (1992) 1.54
The action of calcium-dependent protease on platelet surface glycoproteins. Arch Biochem Biophys (1983) 1.44
Prenatal care and infant lead exposure. J Pediatr (1997) 1.41
Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol (1995) 1.39
Influence of hypothermic cardiopulmonary bypass on atrial natriuretic factor levels. Can J Anaesth (1989) 1.39
Recent advances in research on fibronectin and other cell attachment proteins. J Cell Biochem (1985) 1.38
Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc Natl Acad Sci U S A (1986) 1.37
Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol (1995) 1.35
Transformation-sensitive cell surface protein: isolation, characterization, and role in cellular morphology and adhesion. Ann N Y Acad Sci (1978) 1.34
Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol (1995) 1.30
Variability in transport rates of secretory glycoproteins through the endoplasmic reticulum and Golgi in human hepatoma cells. J Biol Chem (1985) 1.25
Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells. J Clin Invest (1988) 1.18
Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril (1996) 1.16
Role of carbohydrate in biological function of the adhesive glycoprotein fibronectin. Proc Natl Acad Sci U S A (1979) 1.15
Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat-inactivated sera. Infect Immun (1995) 1.12
Tunicamycin-induced alterations in the synthesis of sulfated proteoglycans and cell surface morphology in the chick embryo fibroblast. Exp Cell Res (1979) 1.12
Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res (1986) 1.12
Carbohydrates selectively protect a specific domain of fibronectin against proteases. J Biol Chem (1982) 1.11
An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. J Immunol (1994) 1.08
Phosphorylation of filamin and other proteins in cultured fibroblasts. Biochem Biophys Res Commun (1977) 1.07
Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria. Infect Immun (1994) 1.06
Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells. Am J Pathol (1996) 1.05
Function of the carbohydrate moieties of glycoproteins. J Cell Biochem (1982) 1.04
Cell surface myosin in cultured fibroblasts. Cell (1976) 1.03
Development of time-resolved immunofluorometric assay of vascular permeability factor. Clin Chem (1992) 1.03
Inhibition of complement alternative pathway function with anti-properdin monoclonal antibodies. Mol Immunol (2000) 1.02
Collagen can modulate cell interactions with fibronectin. J Cell Biol (1985) 1.01
Trends in the pattern of blindness and major ocular diseases in Singapore and Asia. Ann Acad Med Singapore (1998) 1.01
Causes and management of Descemet's membrane detachment associated with cataract surgery--not always a benign problem. Ann Acad Med Singapore (2001) 0.99
Cis-polyunsaturated fatty acids stimulate beta1 integrin-mediated adhesion of human breast carcinoma cells to type IV collagen by activating protein kinases C-epsilon and -mu. Cancer Res (2001) 0.98
Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochem Biophys Res Commun (1991) 0.98
Interferon treatment inhibits glycosylation of a viral protein. Nature (1980) 0.97
A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS. J Leukoc Biol (1993) 0.97
Inhibition of fusion of embryonic muscle cells in culture by tunicamycin is prevented by leupeptin. J Cell Biol (1981) 0.97
Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway. J Biol Chem (2000) 0.97
Role of fibronectin in adhesion, migration, and metastasis. Cancer Invest (1989) 0.97
Structural and functional comparisons of chicken and human cellular fibronectins. J Biol Chem (1984) 0.96
The 503-nm pigment of Escherichia coli B: characterization and nutritional conditions affecting its accumulation. J Bacteriol (1973) 0.94
Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. Mol Hum Reprod (1998) 0.92
Structure and function of the fibronectins. Prog Clin Biol Res (1980) 0.91
Regulation of the adhesion of a human breast carcinoma cell line to type IV collagen and vitronectin: roles for lipoxygenase and protein kinase C. Cancer Res (1996) 0.91
Carbohydrate requirement for expression and stability of acetylcholine receptor on the surface of embryonic muscle cells in culture. Proc Natl Acad Sci U S A (1980) 0.89
Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice. Br J Cancer (2010) 0.88
Diminished content of plasma membrane-associated myosin in transformed fibroblasts. Nature (1976) 0.88
Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator. Cancer Res (1988) 0.88
A bad start for socioeconomically disadvantaged children. Environ Health Perspect (1996) 0.87
Reactivity of monoclonal antibody E5 with endotoxin. I. Binding to lipid A and rough lipopolysaccharides. Circ Shock (1992) 0.87
Plasminogen activator and the membrane of transformed cells. Prog Clin Biol Res (1980) 0.86
Up-regulation of vascular endothelial growth factor production by iron chelators. Cancer Res (1996) 0.86
Arterial chondroitin sulfate proteoglycan: localization with a monoclonal antibody. J Histochem Cytochem (1988) 0.86
Fibronectin and integrins in cell adhesion and migration. Biochem Soc Trans (1991) 0.85
Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity. Br J Cancer (1999) 0.85
Selective cytotoxicity of tunicamycin for transformed cells. Int J Cancer (1979) 0.85